A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia
- PMID: 21437635
- DOI: 10.1007/s12185-011-0813-z
A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia
Abstract
Primary familial and congenital polycythaemia (PFCP) is a rare form of inherited erythrocytosis caused by heterozygous mutations in the erythropoietin receptor gene (EPOR). We present a novel mutation in the EPOR in a 15-year-old male who was referred to our clinic for investigation of a persistently elevated haemoglobin level. A significant family history of unexplained erythrocytosis spanning four generations of the patient's family was established. The family history was also significant for an apparent increased rate of cerebrovascular disease in individuals with erythrocytosis. The mutation detected in our patient resides in exon 8 of EPOR, similar to all other EPOR mutations responsible for PFCP. These mutations result in truncation of the cytoplasmic domain of the receptor and impair down-regulation of signalling via the erythropoietin receptor (EPOR). Clinical manifestations in published cases have varied widely and there is a paucity of firm recommendations regarding the management of affected patients. Given the strong family history of complications attributable to erythrocytosis we have recommended venesection with a haematocrit target of ≤0.45 for our patient.
Similar articles
-
Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.Blood. 1995 Jul 1;86(1):15-22. Blood. 1995. PMID: 7795221
-
Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor.Br J Haematol. 1997 Oct;99(1):222-7. doi: 10.1046/j.1365-2141.1997.3583172.x. Br J Haematol. 1997. PMID: 9359528
-
Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.Blood. 1997 Sep 1;90(5):2057-61. Blood. 1997. PMID: 9292543
-
Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.Br J Haematol. 2010 Mar;148(6):844-52. doi: 10.1111/j.1365-2141.2009.08069.x. Epub 2010 Jan 20. Br J Haematol. 2010. PMID: 20096014 Free PMC article. Review.
-
"Benign erythrocytosis" and other familial and congenital polycythemias.Eur J Haematol. 1996 Oct;57(4):263-8. Eur J Haematol. 1996. PMID: 8982288 Review.
Cited by
-
A case of primary familial congenital polycythemia with a novel EPOR mutation: possible spontaneous remission/alleviation by menstrual bleeding.Int J Hematol. 2018 Sep;108(3):339-343. doi: 10.1007/s12185-018-2435-1. Epub 2018 Apr 5. Int J Hematol. 2018. PMID: 29623657
-
Investigation of genetic disturbances in oxygen sensing and erythropoietin signaling pathways in cases of idiopathic erythrocytosis.Genet Res Int. 2013;2013:495724. doi: 10.1155/2013/495724. Epub 2013 Dec 2. Genet Res Int. 2013. PMID: 24363938 Free PMC article.
-
New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis.Haematologica. 2018 Apr;103(4):575-586. doi: 10.3324/haematol.2017.176370. Epub 2017 Dec 21. Haematologica. 2018. PMID: 29269524 Free PMC article.
-
Identification of Two Novel EPOR Gene Variants in Primary Familial Polycythemia: Case Report and Literature Review.Genes (Basel). 2022 Sep 20;13(10):1686. doi: 10.3390/genes13101686. Genes (Basel). 2022. PMID: 36292571 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources